This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Verdoux H, Tournier M, Bégaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010;121:4-10.VerdouxHTournierMBégaudB. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand2010;121:4-10.10.1111/j.1600-0447.2009.01425.x20059452Search in Google Scholar
Alessi-Severini S, Biscontri RG, Collins DM, Sareen J, Enns MW. Ten years of antipsychotic prescribing to children: a Canadian population-based study. Can J Psychiatry 2012:57:52-58.Alessi-SeveriniSBiscontriRGCollinsDMSareenJEnnsMW. Ten years of antipsychotic prescribing to children: a Canadian population-based study. Can J Psychiatry2012:57:52-58.10.1177/07067437120570010922296959Search in Google Scholar
Rani F, Murtay ML, Byrne PJ, Wong ICK. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008:123;1002-9.RaniFMurtayMLByrnePJWongICK. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics2008:123;1002-9.10.1542/peds.2007-200818450906Search in Google Scholar
Carlson GA. The dramatic rise in neuroleptic use in children: why do we do it and what does it buy us? Theories from inpatient data 1988-2010. J Child Adolesc Psychopharmacol 2013;23:144-7.CarlsonGA. The dramatic rise in neuroleptic use in children: why do we do it and what does it buy us? Theories from inpatient data 1988-2010. J Child Adolesc Psychopharmacol2013;23:144-7.10.1089/cap.2013.233123607407Search in Google Scholar
Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents and adults with antipsychotics. Arch Gen Psychiatry 2012:69:1247-1256.OlfsonMBlancoCLiuSMWangSCorrellCU. National trends in the office-based treatment of children, adolescents and adults with antipsychotics. Arch Gen Psychiatry2012:69:1247-1256.10.1001/archgenpsychiatry.2012.64722868273Search in Google Scholar
Penfold RB, Stewart C, Hunkeler EM, et al. Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep 2013;15:426. doi:10.1007/s11920-013-0426-8.PenfoldRBStewartCHunkelerEM. Use of antipsychotic medications in pediatric populations: what do the data say?Curr Psychiatry Rep2013;15:426. doi:10.1007/s11920-013-0426-8.10.1007/s11920-013-0426-8416701124258527Search in Google Scholar
Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63:679-685.OlfsonMBlancoCLiuLMorenoCLajeG. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry2006;63:679-685.10.1001/archpsyc.63.6.67916754841Search in Google Scholar
Correll CU. Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients. Internat Rev Psychiatr 2008:20:195-201.CorrellCU. Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients. Internat Rev Psychiatr2008:20:195-201.10.1080/0954026080188917918386212Search in Google Scholar
Walter G, DeLaroche A, Soh N, et al. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Austr Psychiatr 2008;16:253-262.WalterGDeLarocheASohN. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Austr Psychiatr2008;16:253-262.10.1080/1039856080195854918608172Search in Google Scholar
Correll CU. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 2008;69:26-36.CorrellCU. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry2008;69:26-36.Search in Google Scholar
WHO collaborating centre for drug statistics methodology. Available from: http://www.whocc.no/atc_ddd_index/[Accessed 18 March 2011]WHO collaborating centre for drug statistics methodology. Available from: http://www.whocc.no/atc_ddd_index/[Accessed 18 March 2011]Search in Google Scholar
Koelch M, Prestel A, Singer H, et al. Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol 2009;19:765-770.KoelchMPrestelASingerH. Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol2009;19:765-770.10.1089/cap.2009.001820035595Search in Google Scholar
Talka A-K, Kumpulainen K. Psychotropic medication use in children in urgent psychiatric inpatient care. Suom Lääkäril 2015;70:33-38 [In Finnish].TalkaA-KKumpulainenK. Psychotropic medication use in children in urgent psychiatric inpatient care. Suom Lääkäril2015;70:33-38 [In Finnish].Search in Google Scholar
Zito JM, Derivan AT, Kratochvil CJ, Safer DJ, Fegert JM, Greenhill LL. Off-label psychophamacologic prescribing for children: history supports close clinical monitoring. Child Adolesc Psychiatry Ment Health 2008;2:24.ZitoJMDerivanATKratochvilCJSaferDJFegertJMGreenhillLL. Off-label psychophamacologic prescribing for children: history supports close clinical monitoring. Child Adolesc Psychiatry Ment Health2008;2:24.10.1186/1753-2000-2-24256655318793403Search in Google Scholar
Harrison JN, Cluxton-Keller F, Gross D. Prescribing antipsychotics in children: proceed with caution. J Pediatr Health Care 2012;26:139-145.HarrisonJNCluxton-KellerFGrossD. Prescribing antipsychotics in children: proceed with caution. J Pediatr Health Care2012;26:139-145.10.1016/j.pedhc.2011.10.009377802722360933Search in Google Scholar
Vitiello B, Correll C, van Zwieten-Boot B, Zuddas A, Parellada M, Arango C. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychoparmacol 2009;19:629-635.VitielloBCorrellCvan Zwieten-BootBZuddasAParelladaMArangoC. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychoparmacol2009;19:629-635.10.1016/j.euroneuro.2009.04.00819467582Search in Google Scholar
